K-V, Secured Lenders Reach $5M Deal To End Interest Row
The reorganized K-V Pharmaceutical Co. on Tuesday reached a $5 million settlement with a group of senior secured lenders who had sued to obtain $34.7 million in additional interest on the...To view the full article, register now.
Already a subscriber? Click here to view full article